| VANGUARD CAPITAL MANAGEMENT LLC |
| 5.1M |
| $197.1M |
| +0.8% |
| 4.332% |
| 0.00% |
| 5 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 4.9M | $191.3M | +1.7% | 4.203% | 0.01% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.5M | $174.9M | +0.4% | 3.844% | 0.01% |
| 7 | TWO SIGMA INVESTMENTS, LP | 3.9M | $153.6M | -11.2% | 3.375% | 0.11% |
| 8 | MORGAN STANLEY | 3.5M | $136.0M | +15.7% | 2.988% | 0.01% |
| 9 | CITADEL ADVISORS LLC | 2.7M | $104.4M | +2.4% | 2.295% | 0.01% |
| 10 | AMERIPRISE FINANCIAL INC | 2.2M | $84.1M | +28.4% | 1.848% | 0.02% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 2.1M | $81.9M | +0.8% | 1.799% | 0.00% |
| 12 | DIADEMA PARTNERS LP | 2.0M | $78.5M | +70.0% | 1.726% | 9.92% |
| 13 | AMERICAN CENTURY COMPANIES INC | 1.8M | $70.8M | -12.6% | 1.557% | 0.03% |
| 14 | JANE STREET GROUP, LLC | 1.8M | $68.9M | +48.2% | 1.514% | 0.01% |
| 15 | D. E. Shaw & Co., Inc. | 1.7M | $65.6M | +0.3% | 1.441% | 0.03% |
| 16 | BNP PARIBAS FINANCIAL MARKETS | 982K | $38.3M | +81.6% | 0.842% | 0.01% |
| 17 | GOLDMAN SACHS GROUP INC | 943K | $36.8M | -1.8% | 0.808% | 0.00% |
| 18 | UBS Group AG | 936K | $36.5M | -30.5% | 0.803% | 0.00% |
| 19 | JPMORGAN CHASE & CO | 915K | $36.4M | +88.4% | 0.784% | 0.00% |
| 20 | BlackBarn Capital Partners LP | 850K | $33.2M | +36.8% | 0.729% | 2.80% |
| 21 | RAYMOND JAMES FINANCIAL INC | 795K | $31.0M | -61.7% | 0.681% | 0.01% |
| 22 | ExodusPoint Capital Management, LP | 754K | $29.4M | +264.8% | 0.647% | 0.19% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 732K | $28.6M | +3.0% | 0.628% | 0.01% |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 731K | $28.5M | -0.8% | 0.626% | 0.00% |
| 25 | Pictet Asset Management Holding SA | 683K | $26.6M | -1.9% | 0.585% | 0.03% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in VKTX — a direct measure of their conviction.
| 68.00% |
| 8.21 pp |
| $1.81B |
| 46% |
| Q4 2024 | 390 | 3.7% | 76.21% | 0.54 pp | $3.35B | 36% |
| Q3 2024 | 405 | — | 76.75% | — | $5.26B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
67 institutions opened new positions in VKTX during Q2 2026, while 46 fully exited. 306 added to existing positions and 47 trimmed.
VKTX institutional ownership rose by 3.77 percentage points quarter-over-quarter, with a net change of +29 holders.
The top 10 institutions account for 52.3% of all reported 13F value in VKTX, and the top 25 account for 73.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Viking Therapeutics, Inc. (VKTX) Institutional Ownership